Brendan Delaney is Director of Aadi Bioscience, Inc.. Currently has a direct ownership of 20,000 shares of AADI, which is worth approximately $38,600. The most recent transaction as insider was on Sep 26, 2022, when has been sold 20,000 shares (Common Stock) at a price of $12.5 per share, resulting in proceeds of $250,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20K
0% 3M change
0% 12M change
Total Value Held $38,600

Brendan Delaney Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 26 2022
BUY
Grant, award, or other acquisition
$250,000 $12.5 p/Share
20,000 Added 50.0%
20,000 Common Stock

Also insider at

IMMU
IMMUNOMEDICS INC
BD

Brendan Delaney

Director
Pacific Palisades, CA

Track Institutional and Insider Activities on AADI

Follow Aadi Bioscience, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AADI shares.

Notify only if

Insider Trading

Get notified when an Aadi Bioscience, Inc. insider buys or sells AADI shares.

Notify only if

News

Receive news related to Aadi Bioscience, Inc.

Track Activities on AADI